CAIDYA Trademark

Trademark Overview


On Wednesday, August 3, 2022, a trademark application was filed for CAIDYA with the United States Patent and Trademark Office. The USPTO has given the CAIDYA trademark a serial number of 97533870. The federal status of this trademark filing is REGISTERED as of Tuesday, September 24, 2024. This trademark is owned by Clinipace, Inc.. The CAIDYA trademark is filed in the Advertising, Business and Retail Services, Computer & Software Services & Scientific Services, Personal, and Legal & Social Services categories with the following description:

Business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of pharmaceutical, medical, healthcare, and life sciences companies to assist them with clinical research, clinical trials and applications for drug, biologic and device approval; providing independent review of clinical trials for business purposes; Contract research organization (CRO) services, namely, business management in the field of clinical trials, namely, clinical data management

Providing independent review of clinical trials involving human subjects, namely, reviewing research protocols and related information to ensure protection of the rights and welfare of human subjects of research; regulatory compliance consulting in the pharmaceutical, medical, healthcare, and life sciences fields

Contract research organization (CRO) services, namely, monitoring of clinical trials for drugs, biologics and devices of pharmaceutical, medical, healthcare, and life sciences companies for quality control purposes, and clinical trial project management in the nature of design and implementation of clinical trials and quality assurance for all major therapeutic areas, in particular gastroenterology, nephrology, urology, and oncology; consulting services in the field of scientific research in the nature of conducting clinical trials in the pharmaceutical industry, the biotechnology industry and the medical device and diagnostics industries; providing quality assurance services in the field of regulatory submissions to the FDA by life sciences companies to ensure validity and accuracy; product development for others, namely, providing implementation services relating to the development and validation of drugs, biologics and medical devices; Software as a service (SaaS) services featuring...
caidya

General Information


Serial Number97533870
Word MarkCAIDYA
Filing DateWednesday, August 3, 2022
Status700 - REGISTERED
Status DateTuesday, September 24, 2024
Registration Number7517008
Registration DateTuesday, September 24, 2024
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, October 17, 2023

Trademark Statements


Description of MarkThe mark consists of the stylized wording "CAIDYA" with the stylized letters "C" and "A" intertwined together to form an infinity symbol and appearing in the color pink.
Indication of Colors claimedThe color(s) pink is/are claimed as a feature of the mark.
Goods and ServicesBusiness consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of pharmaceutical, medical, healthcare, and life sciences companies to assist them with clinical research, clinical trials and applications for drug, biologic and device approval; providing independent review of clinical trials for business purposes; Contract research organization (CRO) services, namely, business management in the field of clinical trials, namely, clinical data management
Translation of Words in MarkThe wording "CAIDYA" has no meaning in a foreign language.
Goods and ServicesProviding independent review of clinical trials involving human subjects, namely, reviewing research protocols and related information to ensure protection of the rights and welfare of human subjects of research; regulatory compliance consulting in the pharmaceutical, medical, healthcare, and life sciences fields
Goods and ServicesContract research organization (CRO) services, namely, monitoring of clinical trials for drugs, biologics and devices of pharmaceutical, medical, healthcare, and life sciences companies for quality control purposes, and clinical trial project management in the nature of design and implementation of clinical trials and quality assurance for all major therapeutic areas, in particular gastroenterology, nephrology, urology, and oncology; consulting services in the field of scientific research in the nature of conducting clinical trials in the pharmaceutical industry, the biotechnology industry and the medical device and diagnostics industries; providing quality assurance services in the field of regulatory submissions to the FDA by life sciences companies to ensure validity and accuracy; product development for others, namely, providing implementation services relating to the development and validation of drugs, biologics and medical devices; Software as a service (SaaS) services featuring software for accessing, collecting, managing, tracking, analyzing, and reporting data and information on clinical trials; Contract research organization (CRO) services, namely, custom technical writing for others for non-advertising purposes in the nature of medical writing of clinical study protocols and reports; Contract research organization (CRO) services, namely, custom writing for others for non-advertising purposes in the nature of medical writing of clinical study protocols and reports for submission to regulatory authorities

Classification Information


International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateThursday, August 25, 2022
Primary Code035
First Use Anywhere DateMonday, October 3, 2022
First Use In Commerce DateMonday, October 3, 2022

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, August 25, 2022
Primary Code042
First Use Anywhere DateMonday, October 3, 2022
First Use In Commerce DateMonday, October 3, 2022

International Class045 - Legal services; security services for the protection of property and individuals; personal and social services rendered by others to meet the needs of individuals.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, August 25, 2022
Primary Code045
First Use Anywhere DateMonday, October 3, 2022
First Use In Commerce DateMonday, October 3, 2022

Trademark Owner History


Party NameClinipace, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressMorrisville, NC 27560

Party NameClinipace, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressMorrisville, NC 27560

Party NameClinipace, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMorrisville, NC 27560

Trademark Events


Event DateEvent Description
Saturday, August 6, 2022NEW APPLICATION ENTERED
Thursday, August 25, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, May 19, 2023ASSIGNED TO EXAMINER
Thursday, June 1, 2023NON-FINAL ACTION WRITTEN
Thursday, June 1, 2023NON-FINAL ACTION E-MAILED
Thursday, June 1, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, September 1, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, September 1, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, September 1, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, September 7, 2023EXAMINERS AMENDMENT -WRITTEN
Thursday, September 7, 2023EXAMINERS AMENDMENT E-MAILED
Thursday, September 7, 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, September 7, 2023EXAMINER'S AMENDMENT ENTERED
Thursday, September 7, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, October 17, 2023PUBLISHED FOR OPPOSITION
Tuesday, October 17, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, September 27, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 12, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, June 12, 2024USE AMENDMENT FILED
Wednesday, June 12, 2024TEAS STATEMENT OF USE RECEIVED
Thursday, August 1, 2024STATEMENT OF USE PROCESSING COMPLETE
Saturday, August 17, 2024ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Saturday, August 17, 2024NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, September 24, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, September 24, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Thursday, August 1, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL